[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
Archive ::
For Authors::
For Reviewers::
Ethical Code::
Subscription::
Contact us::
Peer Review Process::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 3, Issue 3 (10-2019) ::
Ir J Physiol Pharmacol 2019, 3(3): 177-169 Back to browse issues page
The effect of magnesium oxide nanoparticles on cyclophosphamide induced anxiety and involvement of muscarinic receptors in male mice
Mahnaz Kesmati * , Elham Rahimifar
Department of Biology, Faculty of Science, Shahid Chamran University Ahvaz, Ahvaz, Iran
Abstract:   (2064 Views)
Background and aims: The anxiolytic effect of magnesium oxide nanoparticles has been determined, but its effect on the reduction of anxiety caused by cyclophosphamide is unknown.  The aim of this study was to evaluate the effect of magnesium oxide nanoparticles on the anxiety resulted from cyclophosphamide and interaction of cholinergic muscarinic receptor activity with it in the adult male mice.
Methods: In this experimental study, 84 adult male NMRI mice (25-35 g) were divided into 12 (n=7) groups including: control (saline, 5 ml/kg), magnesium oxide nanoparticles (2.5 and 5 mg/kg), cyclophosphamide (50 mg/kg),  magnesium oxide nanoparticles 2.5 or 5 mg/kg with cyclophosphamide 50,  scopolamine (1mg/kg), scopolamine 1 with magnesium oxide nanoparticles 2.5 or 5 mg/kg, scopolamine 1 with cyclophosphamide 50, scopolamine  1 and magnesium oxide nanoparticles 2.5 or 5 mg/kg and cyclophosphamide 50. All drugs were injected intraperitoneally and anxiety and motor activity of animals were evaluated by the elevated plus maze apparatus.
Results: Magnesium oxide nanoparticles (2.5 and 5) prevented the anxiety of cyclophosphamide (50), while it has no effect on motor activity. The anxiolytic effect of magnesium oxide nanoparticle was reduced in the presence of scopolamine. The effect of cyclophosphamide induced anxiety was reduced in the presence of scopolamine. The preventive effect of magnesium oxide nanoparticle on the anxiety of cyclophosphamide was reduced in the presence of scopolamine.
Conclusion: It seems that cholinergic muscarinic receptors interfere in the anxiolytic effect of magnesium oxide nanoparticle alone and in combination with cyclophosphamide.
 
 
 
Keywords: Anxiety, Cyclophosphamide, Muscarinic receptor, Nanoparticles, Magnesium oxide
Full-Text [PDF 881 kb]   (668 Downloads)    
Type of Study: Original Research | Subject: Neuroscience
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kesmati M, Rahimifar E. The effect of magnesium oxide nanoparticles on cyclophosphamide induced anxiety and involvement of muscarinic receptors in male mice. Ir J Physiol Pharmacol 2019; 3 (3) :177-169
URL: http://ijpp.phypha.ir/article-1-390-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3, Issue 3 (10-2019) Back to browse issues page
مجله فیزیولوژی و فارماکولوژی ایران Iranian Journal of Physiology and Pharmacology
Persian site map - English site map - Created in 0.09 seconds with 36 queries by YEKTAWEB 4645